Fighting Antimicrobial Resistance: Who Should Lead the Agenda?
Author contribution
WS: Chaired the Antimicrobial agents' usage, antimicrobial resistance and policy symposium at the 6th East African Health and Scientific Research Conference, 28th - 31st March 2017, Bujumbura, Burundi. He collated, interpreted and contextualized symposium recommendations that form the basis of this comment. Wrote and submitted the recommendations report to the East African Health and Research Commission for incorporation into the East African Community policy on Antimicrobial Resistance.
Acknowledgements
Co-chair, Helen Meme1 PhD; Expert presenters, Benon Asiimwe2 PhD and John Ndemi Kiiru1 PhD for their educative talks on the burden and drivers of antimicrobial resistance in East Africa; Panellists, Henry Kajumbula2 MMed, Adam Fimbo3 B.Pharm, Amoreen Naluyima4 MSc, Emmanuel BAMENYEKANYE5, B.Pharm and Jarred Okoyo Nyakiba6 PhD for contextualising the discussion into the national policy frameworks. Fred Njeleka7 BSc for transcribing and digitising the recommendations. TWENDE consortium for sponsoring the symposium and funding from EDCTP, the East African Health Research Commission for hosting the conference and their leadership on AMR policy formulation for the EAC. 1Kenya Medical Research Institute, 2Makerere University Uganda, 3Tanzania Food and Drug Authority, 4National Drug Authority Uganda, 5Ministry of Health Burundi, 6Pharmaceuticals and Poisons Board Kenya, 7NIMR- Mbeya Medical Research Centre.
Funding
The TWENDE consortium (https://infection.st- andrews.ac.uk/twende-overview/) is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). The funder did not participate in writing this comment nor did they influence decision to publish it in the Lancet. The author declares no conflict of interest.
References
-
O'Neill J (2014) The Review on Antimicrobial Resistance Commission. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations.
-
PGA Press Releases (2016) General Assembly of the United Nations POT7S. Press Release: High level Meeting on Antimicrobial Resistance 1-5.
-
Mendelson M, Rottingen JA, Gopinathan U, Hamer DH, Wertheim H, et al. (2016) Antimicrobials: access and sustainable effectiveness 3 Maximising access to achieve appropriate human antimicrobial use in low income and middle-income countries. The Lancet 387(10014): 188-198.
-
Kiiru JN (2017) Antimicrobial resistance In East Africa. Trends, Drivers, Challenges and Future Outlooks. Bujumbura 1-32.
-
Asiimwe B (2017) The Human-Animal Interface: Impact on the Use of Antimicrobial Agents and Spread of Antimicrobial Resistance. Bujumbura 1- 19.
-
Holmes AH, Moore LSP, Sundsfjord A (2016) Antimicrobials: access and sustainable effectiveness 2 Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet 387: 176-187.
- Epidemiological and Clinical Aspects of Intestinal Parasitoses Among Students in the City of Bocaranga, Central African Republic
- Artificial Intelligence Empowers Global Infectious Disease Prevention and Control: Opportunities and Challenges
- Factors that Affect the Incidence of Babesia and Blood Donor Testing in Select States: A Regression Analysis
- Neuro-TB: The Battle between Tuberculosis and the Nervous System
- The Biological and Health Implications of Cat Fleas (Ctenocephalides felis): Assessing Zoonotic Risks and Hygiene Strategies
- Biostatistical Analysis of Medicinal Plants for Treating Schizophrenia